Drugs that contain Vandetanib

1. Drug name - CAPRELSA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE42353 GENZYME CORP Quinazoline derivatives and pharmaceutical compositions containing them
Jun, 2022

(3 months ago)

CN1142920C GENZYME CORP Quinazoline Derivatives And Pharmaceutical Composition Thereof And Preparation Method And Application Thereof
Sep, 2017

(5 years ago)

CN1231662A GENZYME CORP Quinazoline Derivatives And Pharmaceutical Composition Containing Quinazoline Derivative
Sep, 2017

(5 years ago)

EP929530A1 GENZYME CORP Quinazoline Derivatives And Pharmaceutical Compositions Containing Them
Sep, 2017

(5 years ago)

EP929530B1 GENZYME CORP Quinazoline Derivatives And Pharmaceutical Compositions Containing Them
Sep, 2017

(5 years ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8067427 GENZYME CORP Pharmaceutical compositions comprising ZD6474 Aug, 2028

(5 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
100MG TABLET;ORAL Prescription
300MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.